Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
03/2012
03/21/2012CN102388054A Thiazolopyridine sirtuin modulating compounds
03/21/2012CN102387804A Prophylactic or therapeutic agent for diseases associated with abnormal bone metabolism
03/21/2012CN102382187A FBXL15 protein fragment, coding gene thereof, and application of FBXL15 protein fragment and coding gene
03/21/2012CN102382172A Binding agents which inhibit myostatin
03/21/2012CN102382088A 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
03/21/2012CN102380073A Chinese medicament for treating diabetic gout
03/21/2012CN102380072A Externally applied cold wash traditional Chinese medicine composition for activating blood and reliving pain and application thereof
03/21/2012CN102380069A Traditional Chinese medicine for treating diabetes and gout
03/21/2012CN102380066A Traditional Chinese medicine for treating diabetic gout
03/21/2012CN102380057A Chinese patent medicine for treating rheumatism and rheumatoid arthritis
03/21/2012CN102380044A Oral medicament for traditional Chinese medicine treatment of cervical spondylosis
03/21/2012CN102380022A Collateral activating tibia medicine for external application
03/21/2012CN102380015A Medicinal composition for treating rheumatoid arthritis and preparation method and application thereof
03/21/2012CN102379999A Medicinal combination for treating rheumatoid disease and preparation method thereof
03/21/2012CN102379987A Snake medicine alcohol liniment for treating rheumatoid bone pains
03/21/2012CN102379971A Compound propolis composition for treating cage layer fatigue and preparation method thereof
03/21/2012CN102379941A Chinese medicinal compound preparation for treating fracture and preparation method thereof
03/21/2012CN102379934A High efficiency liquid chromatography detection method for content of raddeanin A in rhizoma anemones raddeanae
03/21/2012CN102379916A Bone mineral density increase capsule and preparation method thereof
03/21/2012CN102379907A Ganoderma lucidum double vitamin methionine preparation and production method thereof
03/21/2012CN102379874A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
03/21/2012CN102379869A Oral preparation containing saxagliptin and application thereof
03/21/2012CN102379843A Levocarnitine pharmaceutical composition for injection
03/21/2012CN101919859B Medicinal composition containing pentoxifyllinum and etodolic acid and application thereof
03/21/2012CN101732579B Medicinal composition for treating rheumatism and rheumatoid arthritis
03/21/2012CN101732386B Medicinal composition for treating gout, preparation method thereof and purposes thereof
03/21/2012CN101721706B Medicine composition containing matrine class alkaloid, preparation method and pharmaceutical application
03/21/2012CN101721651B Traditional Chinese medicine capsule for treating scapulohumeral periarthritis
03/21/2012CN101711786B Preparation used for relieving osteoarthropathy and enhancing immunity
03/21/2012CN101530484B Blood-activating bone-strengthening plaster
03/21/2012CN101507784B Traditional Chinese medicine capable of promoting fracture healing
03/21/2012CN101496875B External-use medical ointment for bone fracture
03/21/2012CN101406565B Pepper Babu plaster for rheumatism and method for producing the same
03/21/2012CN101175501B Production of glucosamine from plant species
03/21/2012CN101057845B Bulleyaconitin A dry emulsion and its preparation method and application
03/21/2012CN101007803B Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
03/20/2012US8138338 Aurora kinase inhibitors from an encoded small molecule library
03/20/2012US8138337 Reverse-turn mimetics and method relating thereto
03/20/2012US8138335 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
03/20/2012US8138311 Modified proteins, designer toxins, and methods of making thereof
03/20/2012US8138305 Glucagon-like peptide-1 (glp-1) receptor agonist; diabetes, obesity, glucagonomas, secretory disorders of the airway, metabolic disorder, arthritis, osteoporosis, central nervous system disease, restenosis and neurodegenerative disease.
03/20/2012US8138224 Nutritional or therapeutic composition containing the compound oleuropeine or one of the derivatives thereof
03/20/2012US8138195 Inhibitors of human phosphatidylinositol 3-kinase delta
03/20/2012US8138152 Methods of treatment using WISP polypeptides
03/20/2012US8138147 Conditioned cell culture medium compositions and methods of use
03/20/2012US8138141 HMG1 antibody for treating inflammatory conditions
03/20/2012US8137904 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
03/20/2012US8137689 Transplant/implant device and method for its production
03/20/2012US8137685 Reaction product of hyaluronic acid and a phosphatidyl ethanolamine; biocompatibility and bio-safety; formed or molded to shape used to treat a knee joint; prevent accretion of a tissue after an operation; keep skin wet
03/20/2012US8137662 Proliferated cell lines and uses thereof
03/20/2012CA2676907C Tricyclic compounds and their use as glucocorticoid receptor modulators
03/20/2012CA2529749C Omega-3 fatty acids for the treatment of canine osteoarthritis
03/20/2012CA2446872C Immune-modulating peptide
03/20/2012CA2405469C Integrin binding peptide derivatives
03/20/2012CA2402719C Method of preparing alkylated salicylamides via a dicarboxylate intermediate
03/20/2012CA2402210C Collagen membrane carrying therapeutic genetic material for tissue regeneration
03/20/2012CA2363067C Compounds and methods to inhibit or augment an inflammatory response
03/15/2012WO2012034079A2 Macrolide dosage forms
03/15/2012WO2012033941A1 Methods for concomitant treatment of theophylline and febuxostat
03/15/2012WO2012033352A2 Equine amniotic fluid derived multipotent stem cells and a production method therefor
03/15/2012WO2012033272A1 Human-derived cell-permeable peptide bioactive peptide conjugate, and use thereof
03/15/2012WO2012033195A1 Heterocyclic compound
03/15/2012WO2012032513A1 Boranophosphate derivatives for the treatment of osteoarthritis
03/15/2012WO2012003477A3 Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors
03/15/2012WO2011139886A3 Preparation of febuxostat
03/15/2012WO2011130611A3 Treating disorders associated with il-20 receptor-mediated signaling pathway by blocking il-20 receptor activity
03/15/2012WO2011118954A3 Method for differentiating cartilage cells, bone cells, nerve cells or fat cells from human inferior turbinate mesenchymal stromal cells
03/15/2012US20120066781 Phytases, nucleic acids encoding them and methods for making and using them
03/15/2012US20120066778 Control of uric acid homeostasis
03/15/2012US20120065641 Methods and devices for repairing bone defects
03/15/2012US20120065574 Isoform nell-1 peptide
03/15/2012US20120065380 Dual targeting antibody of novel form, and use thereof
03/15/2012US20120065236 Methods for concomitant treatment of theophylline and febuxostat
03/15/2012US20120065232 Photostabilization of retinoids with alkoxycrylene compounds
03/15/2012US20120065231 Thiophene derivative
03/15/2012US20120065219 Spirocyclic azaadamantane derivatives and methods of use
03/15/2012US20120065216 Quinazolinedione derivatives as parp inhibitors
03/15/2012US20120065207 Methods for concomitant treatment of theophylline and febuxostat
03/15/2012US20120065201 Inhibitors of bruton's tyrosine kinase
03/15/2012US20120065200 Inhibitors of notum pectinacetylesterase and methods of their use
03/15/2012US20120065192 N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as mps1 kinase inhibitors
03/15/2012US20120065191 Pharmaceutical compounds
03/15/2012US20120065183 Tetrahydro-Pyrido-Pyrimidine Derivatives
03/15/2012US20120065180 Androgen pharmaceutical composition and method for treating depression
03/15/2012US20120065166 Bone Modulators And Methods Therewith
03/15/2012US20120065151 Substances Mixture, Use and Infusion Solution
03/15/2012US20120065140 Biomarkers for the Diagnosis of Autoimmune Disease
03/15/2012US20120064625 Nucleic Acids, Polypeptides, Compositions, and Methods for Modulating Apoptosis
03/15/2012US20120064571 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use
03/15/2012US20120064544 Methods of Diagnosing Hypophosphatemic Disorders
03/15/2012US20120064179 Bicarbonate solution for bioavailable magnesium and uses thereof
03/15/2012US20120064172 Bone filling material comprising sintered titanium dioxide and dextrin and method for reconstructing bone defects using the same
03/15/2012US20120064170 Gallium-Doped Phosphocalcic Compounds
03/15/2012US20120064157 Pharmaceutical composition and administrations thereof
03/15/2012US20120064124 Macrolide dosage forms
03/15/2012US20120064122 Treatment of autoimmune inflammation using mir-155
03/15/2012US20120064081 Anti-kir3d antibodies
03/15/2012US20120064077 Stable and soluble antibodies inhibiting tnf alpha
03/15/2012US20120064073 Il-17 homologous polypeptides and therapeutic uses thereof
03/15/2012US20120064060 Compound having s1p receptor binding potency and use thereof
1 ... 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 ... 820